Van Der Laan JW - Search Results

1

Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats.

De Waal EJ, Van Der Laan JW, Van Loveren H. De Waal EJ, et al. Among authors: van der laan jw, van loveren h. Toxicology. 1998 Aug 21;129(2-3):201-10. doi: 10.1016/s0300-483x(98)00077-8. Toxicology. 1998. PMID: 9772098

2

Immunotoxicological screening of morphine and methadone in an extended 28 day study in rats.

van der Laan JW, Krajnc EI, Krajnc-Franken MA, van Loveren H. van der Laan JW, et al. Among authors: van loveren h. Int J Immunopharmacol. 1995 Jun;17(6):535-43. doi: 10.1016/0192-0561(95)00010-y. Int J Immunopharmacol. 1995. PMID: 7499032

3

Comparison of the in vivo effects of morphine and methadone on natural killer cell activity in spleen, peritoneal cavity, and lungs in rats.

Van der Laan JW, Timmerman H, Van Loveren H. Van der Laan JW, et al. Among authors: van loveren h. Int J Immunopharmacol. 1996 Jun-Jul;18(6-7):401-7. doi: 10.1016/s0192-0561(96)00011-2. Int J Immunopharmacol. 1996. PMID: 9024942

4

Current status and burning issues in immunotoxicity testing of drugs.

van der Laan JW, van Loveren H. van der Laan JW, et al. Among authors: van loveren h. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):435-40. doi: 10.1016/j.taap.2005.02.030. Toxicol Appl Pharmacol. 2005. PMID: 15982690 Review.

5

Assessment of immunotoxicity of buprenorphine.

Van Loveren H, Gianotten N, Hendriksen CF, Schuurman HJ, Van der Laan JW. Van Loveren H, et al. Among authors: van der laan jw. Lab Anim. 1994 Oct;28(4):355-63. doi: 10.1258/002367794780745119. Lab Anim. 1994. PMID: 7830376

6

Interspecies extrapolation in safety evaluation of human medicines in The Netherlands (1990-1992): practical considerations.

Peters-Volleberg GW, De Waal EJ, Van der Laan JW. Peters-Volleberg GW, et al. Among authors: van der laan jw. Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 1):248-58. doi: 10.1006/rtph.1994.1075. Regul Toxicol Pharmacol. 1994. PMID: 7724833

7

The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe.

Van Oosterhout JP, Van der Laan JW, De Waal EJ, Olejniczak K, Hilgenfeld M, Schmidt V, Bass R. Van Oosterhout JP, et al. Among authors: van der laan jw. Regul Toxicol Pharmacol. 1997 Feb;25(1):6-17. doi: 10.1006/rtph.1996.1077. Regul Toxicol Pharmacol. 1997. PMID: 9056497

8

Assessing immunotoxicity: guidelines.

Putman E, van der Laan JW, van Loveren H. Putman E, et al. Among authors: van der laan jw, van loveren h. Fundam Clin Pharmacol. 2003 Oct;17(5):615-26. doi: 10.1046/j.1472-8206.2003.00181.x. Fundam Clin Pharmacol. 2003. PMID: 14703723 Review.

9

Immune function testing of human pharmaceuticals: regulatory overshoot?

van der Laan JW, van Loveren H. van der Laan JW, et al. Among authors: van loveren h. Expert Opin Drug Saf. 2005 Jan;4(1):1-5. doi: 10.1517/14740338.4.1.1. Expert Opin Drug Saf. 2005. PMID: 15709893

10

Statins accelerate the onset of collagen type II-induced arthritis in mice.

Vandebriel RJ, De Jong HJ, Gremmer ER, Klungel OH, Tervaert JW, Slob W, Van Der Laan JW, Van Loveren H. Vandebriel RJ, et al. Among authors: van der laan jw, van loveren h. Arthritis Res Ther. 2012 Apr 26;14(2):R90. doi: 10.1186/ar3814. Arthritis Res Ther. 2012. PMID: 22537858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters